Meropenem Kalceks (Meropenem)

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections affecting various organ systems.

• Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure.
• Complicated skin and soft tissue infections: provides rapid resolution of infection.
• Meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections.
• Pneumonia: effective against resistant respiratory pathogens.
• Sepsis: supports systemic infection control and improves survival outcomes.

• Meropenem inhibits bacterial cell wall synthesis by binding with high affinity to penicillin‑binding proteins. This binding disrupts the cross‑linking of peptidoglycan strands, leading to loss of cell wall integrity, osmotic instability, and ultimately bacterial cell lysis and death. The drug is stable against most β‑lactamases, giving it activity against a wide range of Gram‑positive and Gram‑negative organisms.

Adverse reactions may occur with meropenem therapy and are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Diarrhea: may be watery and self‑limiting.
• Headache: transient cranial pain.
• Infusion site phlebitis: redness or pain at the IV site.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or CNS disorders.
• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Clostridioides difficile‑associated diarrhea: potentially life‑threatening colitis.
• Neutropenia or thrombocytopenia: marked reductions in white blood cells or platelets.

Meropenem should be used with careful clinical assessment and monitoring.

• Renal function: adjust dose in patients with impaired renal clearance.
• Allergy history: avoid in individuals with known carbapenem hypersensitivity.
• Seizure risk: monitor patients with a history of seizures or CNS disorders.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant.
• Drug interactions: review concomitant medications for possible interactions.

Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Valproic acid: may lower valproate levels, risking seizure breakthrough.
• CNS depressants: additive central nervous system depression.
• Nephrotoxic agents (e.g., aminoglycosides): heightened risk of renal injury.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may increase meropenem plasma concentrations.
• Warfarin: potential enhancement of anticoagulant effect.
• Probenecid: can reduce renal clearance, raising meropenem exposure.